Imaging is one of the key technologies that are enabling advances in well-based screening studies, and multilabeled detection using plate-reading technologies is the foundation of screening platforms for drug discovery. As lead generation seeks to become more targeted and more clinically relevant, we see trends at all levels of automation as well as a movement from classical high throughput screens using over-expressing cell lines, to the use of phenotypic cell lines, high content analysis, and miniaturization. In this webinar, the second in a series of three exploring imaging from cell to well to animal, our panelists will focus on the use of well-based imaging technology, now and in the future. They will consider the role of screening in providing unbiased, statistically relevant data and the challenges faced in data management and image analysis. They will also explore the developing trends in establishing collaborations with academia and outsourcing through external organizations and the benefits that these links bring to the advancement of disease research.
During the webinar, our panelists will:
- Consider the application of new technologies in drug discovery
- Discuss the challenges faced when using well-based imaging
- Examine how academic-industry collaborations might drive discovery
For related products/technologies go to: www.perkinelmer.com/imaging.